The in vitro ingredient demonstrated that both of those glucagon and Retatrutide straight decreased ANGPTL3/8 secretion from hepatocytes, which effect was blocked by a glucagon receptor (GCGR) antagonist. These results propose which the GCGR agonism of Retatrutide contributes to the reduction in circulating ANGPTL3/eight, which in turn may perhaps